Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

GRT-R904

Alternative Names: grt-r904, grt r904, grtr904
Latest Update: 2024-05-21
Latest Update Note: Clinical Trial Update

Product Description

self-amplifying mRNA vector

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Nucleic Acid

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Gritstone Oncology
Company Location: EMERYVILLE CA 94608
Company CEO: Andrew Allen
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for GRT-R904

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Colorectal Cancer|Non-Small-Cell Lung Cancer|Pancreatic Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
GO-005

P2

Completed

Non-Small-Cell Lung Cancer|Pancreatic Cancer|Colorectal Cancer

2023-03-10

57%
GO-005

P2

Completed

Non-Small-Cell Lung Cancer|Pancreatic Cancer|Colorectal Cancer

2023-03-10

57%

Recent News Events

Date

Type

Title

09/17/2021

News Article

 Gritstone Announces Dosing of First Solid Tumor Patient with Optimized SLATE "Off-the-Shelf" Mutant KRAS-directed Neoantigen Immunotherapy in Phase 2 Clinical Trial

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions